Pegintron/Rebetol Combo Pack (peginterferon alfa-2b + ribavirin) / Merck (MSD)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegintron/Rebetol Combo Pack (peginterferon alfa-2b + ribavirin) / Merck (MSD)
NCT01838772: HCV Treatment in HIV Co-Infected Patients in Asia

Completed
4
188
RoW
Pegylated-Interferon and Ribavirin, PegIntron, Rebetol
amfAR, The Foundation for AIDS Research, Kirby Institute
Hepatitis C, HIV
06/16
09/16
2004-001220-20: Efficacy and Safety of PEG-Intron plus Rebetol in Subjects with Chronic Hepatitis C Genotype 1 Non Responder to Pegasys

Completed
3/4
200
Europe, RoW
Pegintron, Rebetol, SCH 54031, SCH 18908, Injection*, Capsule, hard, PegIntron, Rebetol
Integrated Therapeutics Group, Incorporated - a subsidiary of Schering-Plough, Integrated Therapeutics Group, Incorporated- a subsidiary of Schering Plough, SCHERING-PLOUGH
Chronic Hepatitis C, Genotype 1
 
 

Download Options